Urokinase for Thrombolysis in Acute Ischemic Stroke

NARecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 25, 2025

Primary Completion Date

September 25, 2026

Study Completion Date

December 25, 2026

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Urokinase thrombolysis

The intravenous thrombolysis group was administered urokinase dissolved in 100 mL of saline via continuous intravenous infusion for 30 min, and the treatment was given within 6 h of stroke onset. The dose escalation plan includes the following increments: 15,000 IU/kg (maximum dose: 1.5 million IU), 20,000 IU/kg (maximum dose: 2.0 million IU), and 25,000 IU/kg (maximum dose: 2.5 million IU).

Trial Locations (1)

100053

RECRUITING

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Capital Medical University

OTHER

NCT07047326 - Urokinase for Thrombolysis in Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter